Inhaled anti-muscarinic agents as contingency mcms against nerve agent-induced bronchorrhea

Ended Awarded Last action

Contract number
75A50122F61001
Awardee
Awarding agency
Obligated
$3,581,970

Award facts

Contract value 100% obligated
$3,581,970.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Funding Only Action P00008 $306,271
Other Administrative Action P00007 $0
Funding Only Action P00006 $180,084
Other Administrative Action P00005 $0
Funding Only Action P00004 $974,726
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $2,120,889
Show all 11

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response awarded Battelle Memorial Institute a $3.58 million cost-plus-fixed-fee delivery order on September 23, 2022, for research and development of inhaled anti-muscarinic agents as contingency medical countermeasures against nerve agent-induced bronchorrhea. The contract includes supplemental funding to address higher-than-expected model development costs necessary to complete the remaining medical countermeasure efficacy study task. Work is being performed in Columbus, Ohio, with an ultimate completion date of September 30, 2024. The award was not designated as a set-aside and represents an investment in preparedness medical countermeasures aligned with ASPR's mission to enhance the nation's ability to prevent, prepare for, and respond to public health emergencies and disasters.

Battelle Memorial Institute, a large nonprofit research and development organization headquartered in Columbus, Ohio, serves as the prime contractor and brings extensive federal contracting experience across defense, homeland security, health, and scientific domains. The contract includes subcontractors Amplifybio LLC, providing veterinary consultation and assistance services, and Veterans Healthcare Supply Solutions, Inc., supplying ventilator equipment and support. Amplifybio LLC's role focuses on non-clinical studies, toxicological evaluations, and veterinary expertise critical to medical countermeasure development, while Veterans Healthcare Supply Solutions contributes specialized medical equipment necessary for research operations. This delivery order leverages Battelle's established capabilities in biomedical research and medical countermeasures development, building on the organization's significant prior work with the National Institute of Allergy and Infectious Diseases and other federal health agencies.

Quick answers

Who was awarded contract 75A50122F61001?

75A50122F61001 was awarded to Battelle Memorial Institute by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 23, 2022.

How much is contract 75A50122F61001 worth?

The government has obligated $3,581,970 on 75A50122F61001.

Is contract 75A50122F61001 an order under another contract?

Yes. 75A50122F61001 is a delivery order under 75A50122D00007, an indefinite delivery contract.

Was contract 75A50122F61001 competed?

The extent of competition for 75A50122F61001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login